Rankings
▼
Calendar
TEVA Q1 2017 Earnings — Teva Pharmaceutical Industries Limited Revenue & Financial Results | Market Cap Arena
TEVA
Teva Pharmaceutical Industries Limited
$36B
Q1 2017 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$5.6B
+17.0% YoY
Gross Profit
$2.8B
50.1% margin
Operating Income
$895M
15.9% margin
Net Income
$580M
10.3% margin
EPS (Diluted)
$0.57
QoQ Revenue Growth
-13.3%
Cash Flow
Operating Cash Flow
$470M
Free Cash Flow
$268M
Stock-Based Comp.
$40M
Balance Sheet
Total Assets
$91.3B
Total Liabilities
$55.5B
Stockholders' Equity
$34.0B
Cash & Equivalents
$900M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$5.6B
$4.8B
+17.0%
Gross Profit
$2.8B
$2.8B
+1.0%
Operating Income
$895M
$1.2B
-23.2%
Net Income
$580M
$570M
+1.8%
← FY 2017
All Quarters
Q2 2017 →